Trial Profile
A Randomised, Double-Blind, Parallel-Group, Flexible-Dose Trial Evaluating the Efficacy and Safety of 12 Weeks of Treatment With Sertindole or Olanzapine in Patients With Schizophrenia in Asia.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 22 Sep 2013
Price :
$35
*
At a glance
- Drugs Sertindole (Primary) ; Olanzapine
- Indications Schizophrenia
- Focus Therapeutic Use
- Sponsors Lundbeck A/S
- 23 Mar 2009 New trial record